Manufacturer record
Daxin Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Daxin Pharmaceuticals Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between December 2023 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
7 records linked to Daxin Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cefixime Dispersible Tablets IP | DB240368Mfg 2024-12 · Exp 2026-11 | The sample does not conform to I.P. w.r.to the tests for AssayAssay | SDTL,GuwahatiState lab | Jul 2026 |
| Cefem -200 Tablets, Cefixime with Lactic Acid Bacillus tablets | DB240126Mfg 2024-04 · Exp 2026-03 | NOT OF STANDARD QUALITY 1. Thirteen Individual weights deviated from the average weight 636.0 mg i.e 6 tablets deviated by less than 5 percent and 7 tablets deviated by more than 5 percent . Hence the sample does not complies the test Uniformity of weight. 2. Assay of Cefixime does not complies. Hence the sample is of NOT OF STANDARD QUALITYAssay | State Lab Drugs Control Laboratory, TelanganaState lab | Oct 2024 |
| Cefoperazone & Sulbactam For Injection (Todaycef 1.5 G) | D0481Mfg 2023-11 · Exp 2025-10 | Clarity of Solution, Particulate matter and AssayAssay | CDL KolkataCDSCO lab | Aug 2024 |
| Cefixime & Ofloxacin Tablets (CEFIKAM OF 200) | DB230057Mfg 2023-02 · Exp 2025-01 | Assay of Cefixime Trihydrate & Assay OfloxacinAssay | CDL KolkataCDSCO lab | Jun 2024 |
| CefuroximeAxetil Tablets IP | DB23030 4Mfg 2023-12 · Exp 2025-11 | The sample does not conforms to claim as per IP 2022in respect to the Test of Dissolution of Cefuroxime Axetil equivalent to CefuroximeDissolution | CDL KolkataCDSCO lab | May 2024 |
| Cefixime & Ofloxacin Tablets | DB23005 7Mfg 2023-02 · Exp 2025-01 | The sample does not conforms to claim as per Schedule V of Drugs & Cosmetics Act with respect to the Assay of Cefixime Trihydrate eq. to anhydrous Cefixime and Assay of OfloxacinAssay | CDL KolkataCDSCO lab | May 2024 |
| Paracetamol Tablets IP 650mg. (DAXIPAR-650 Tablets) | DPT22863Mfg 2022-09 · Exp 2024-08 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.